Skip to main content
VTAK logo

VTAK · Catheter Precision, Inc. · Executive Compensation

Track VTAK — free
$1.62 At close · Oct 5
Market Cap
$217,318
Shares
1.44M
Volume · Oct 5 11.67M Avg daily vol (1 sessions) 11.67M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
David A. Jenkins $519,250
Philip Anderson CFO $406,270
Marie-Claude Jacques $241,750
Margrit Thomassen $173,775
Fiscal 2024
Executive Total
Former CCO $397,292
David A. Jenkins $300,000
Fiscal 2021
Executive Total
Jonathan Will McGuire $911,125
Andrew Jackson $520,701
Daniel Horwood $404,641
Fiscal 2020
Executive Total
Jonathan Will McGuire $1,656,985
Andrew Jackson $874,631
Daniel Horwood $667,698
Fiscal 2019
Executive Total
Andrew Jackson $687,573
Jeffrey J. Kraws $517,522
Daniel Horwood $507,639
Dean S. Irwin $311,983
Fiscal 2018
Executive Total
Dean S. Irwin $10,874,823
Jeffrey J. Kraws $8,914,269

Executive changes

Person Change Filed
David A. Jenkins Appointed 2026-10-02
Marie-Claude Jacques Terminated 2025-06-06
Philip Anderson Appointed 2025-01-07
Andrew Arno Appointed 2024-07-10
James Caruso Appointed 2024-07-10
David Jenkins Appointed 2024-01-04
Margrit Thomassen Appointed 2024-01-04
John P. Francis Appointed 2024-01-04
Susanne Meline Resigned 2023-12-29
David Jenkins Appointed 2023-04-19
Will McGuire Resigned 2023-04-19
Will McGuire Resigned 2023-04-19
Will McGuire Resigned 2023-04-19
Steven Passey Appointed 2023-03-30
James J. Caruso Appointed 2023-01-13
David Jenkins Appointed 2023-01-13
David Jenkins Appointed 2023-01-13
Martin Colombatto Resigned 2023-01-13
James Caruso Appointed 2023-01-13
David Jenkins Appointed 2023-01-13
Joan Stafslien Resigned 2023-01-13
Richard Mejia, Jr. Resigned 2023-01-13
Brian Conn Resigned 2022-09-12
Will McGuire Resigned 2022-09-12
David Jenkins Appointed 2022-09-12
Key facts CIK 1716621 CUSIP 74933X708 Visit website Investor relations